Research/研究

Research/研究

HOME > 研究 > 業績

業績

2022年度

Ⅰ. 原著論文

  1. Komatsu T, Hada T, Sasaki N, Kida H, Takahashi J, Maku T, Nakada R, Shiraishi T, Akiyama S, Kitagawa T, Sato T, Takatsu H, Sakuta K, Sakai K, Umehara T, Omoto S, Murakami H, Mitsumura H, Abo M, Iguchi Y. Effects and safety of high-frequency rTMS in acute intracerebral hemorrhage patients: A pilot study. J Neurol Sci. 2022 Oct; 443: 120473.
  2. Komatsu T, Kida H, Ozawa M, Mimori M, Kokubu T, Takahashi J, Kurihara S, Maku T, Motegi H, Takahashi M, Shiraishi T, Nakada R, Kitagawa T, Sato T, Takatsu H, Sakai K, Umehara T, Omoto S, Murakami H, Mitsumura H, Yokoo T, Iguchi Y. Urinary Immunoglobulin G Is Associated with Deep and Infratentorial Cerebral Microbleeds in Stroke Patients. Cerebrovasc Dis. 2022 Nov 8;1-10. doi: 10.1159/000527019.
  3. Komatsu T, Ohta H, Takakura N, Hata J, Kitagawa T, Kurashina Y, Onoe H, Okano J, Iguchi Y. A Novel Rat Model of Embolic Cerebral Ischemia Using a Cell-Implantable Radiopaque Hydrogel Microfiber. Transl Stroke Res. 2023 Mar 3; doi: 10.1007/s12975-023-01144-6.
  4. Kono Y, Terasawa Y, Sakai K, Iguchi Y, Nishiyama Y, et al. Association between Living Conditions and the Risk Factors, Etiology, and Outcome of Ischemic Stroke in Young Adults. Internal Med. 2023; doi: 10.2169/internalmedicine.0912-22.
  5. Murakami H, Okumura M, Ozawa M, Mimori M, Maku T, Shiraishi T, Kitagawa T, Takatsu H, Sato T, Komatsu T, Sakai K, Umehara T, Omoto S, Mitsumura H, Iguchi Y. Effects of monotherapy with a monoamine oxidase B inhibitor on motor symptoms in Parkinson’s disease are dependent on frontal function. Neurol Sci. 2023;44:913-918.
  6. Okumura M, Sato T, Maku T, Kitagawa T, Takatsu H, Komatsu T, Sakuta K, Sakai K, Umehara T, Mitsumura H, Murakami H, Iguchi Y. Old thalamic lacunes contralateral to a supratentorial intracerebral hemorrhage are associated with an unfavorable outcome. J Neurol Sci. 2022 Dec 12;444:120523.
  7. Omoto S, Saito M, Murakami H, Shiraishi T, Kitagawa T, Sato T, et al. The association between urinary pentosidine levels and cognition in drug-naive patients with Parkinson’s disease. Neurol Sci. 2022;43:6323-8.
  8. Sakuta K, Yaguchi H, Kida H, Sato T, Miyagawa S, Mitsumura H, Fuga M, Ishibashi T, Okuno K, Murayama Y, Iguchi Y. The meaning of non-culprit stenosis in hyperacute stroke with large vessel occlusion. J Neurol Sci. 2022 May 15;436:120247.
  9. Sato T, Sakai K, Okumura M, Kitagawa T, Takatsu H, Tanabe M, Komatsu T, Sakuta K, Umehara T, Murakami H, Mitsumura H, Matsushima M, Iguchi Y. Low Dihomo-γ-Linolenic Acid is Associated With Susceptibility Vessel Sign in Cardioembolism. Thrombosis Research. 2022;213:84-90.
  10. Sato T, Niijima A, Arai A, Maku T, Motegi H, Takahashi M, Takatsu H, Tanabe M, Komatsu T, Sakuta K, Sakai K, Terasawa Y, Umehara T, Omoto S, Murakami H, Mitsumura H, Iguchi Y. Middle cerebral artery pulsatility index correlates with prognosis and diastolic dysfunctions in acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases. 2022;31:106296.
  11. Takahashi J, Mori-Yoshimura M, Ariga H, et al. Diagnostic Yield of Chilaiditi’s Sign in Advanced-Phase Late-Onset Pompe Disease. J Neuromuscul Dis. 2022;9:619-627.
  12. Takahashi J, Okamoto T, Lin Y, et al. Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis. Frontier in immunology 2023; 14: 1-10.
  13. Shiroshita A,Yamamoto N,Saka N,Okumura M,Shiba H,Kataoka Y. Inappropriate evaluation of effect modifications based on categorical outcomes: A systematic review of randomized controlled trials. Int. J. Environ. Res. Public Health 2022;19:15262.
  14. Furube A, Kadota T, Gochi M, Saito S, Shibata S, Inaki S, Tone K, Takagi M, Matsuno H, Araya J, Yaguchi H, Kuwano K. Clinical features of organizing pneumonia in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. Respir Investig. 2022; 60: 684-693.
  15. Hatano T, Kano O, Sengoku R, Yoritaka A, Suzuki K, Nishikawa N, Mukai Y, Nomura K, Yoshida N, Seki M, et al. Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson’s disease: study protocol for the ISTRA ADJUST PD randomized, controlled study. BMC Neurol 2022;22(1):71.
  16. Hayashi T, Suda S, Abe A, Iguchi Y, Yagita Y, Kanzawa T, Okubo S, Fujimoto S, Kimura K, group on behalf of the P study. Sustained atrial fibrillation is related to a higher severity of stroke in patients taking direct oral anticoagulants. J Neurol Sci. 2022;434:120172.
  17. Iida Y, Hayashi T, Tokuhisa T, Mizobuchi K, Omoto S, Nakano T. Polypoidal choroidal vasculopathy in a patient with DMPK-associated myotonic dystrophy. Doc Ophthalmol. 2022;144:217-26.
  18. Ikeda T, Sato T, Komatsu T, Sakai K, Umehara T, Omoto S, Murakami H, Mitsumura H, Matsushima S, Makishima R, Takahashi H, Ishibashi T, Murayama Y, Iguchi Y. Aortogenic emboli might play an important role in the development of delayed leukoencephalopathy after mechanical thrombectomy. Neurology and Clinical Neuroscience. 2023:11;103-106.
  19. Ishizuka K, Hoshino T, Toi S, Mizuno T, Hosoya M, Saito M, Sato Y, Yagita Y, Todo K, Sakaguchi M, Ohashi T, Maruyama K, Hino S, Honma Y, Doijiri R, Yamagami H, Iguchi Y, Hirano T, Kimura K, Kitazono T, Kitagawa K. Remote ischemic conditioning for acute ischemic stroke part 2: Study protocol for a randomized controlled trial. Front Neurol. 2022;13:946431.
  20. Kurihara M, Komatsu H, Sengoku R, Shibukawa M, Morimoto S, Matsubara T, Arakawa A, Orita M, Ishibashi K, Mitsutake A, Shibata S, Ishiura H, Adachi K, Ohse K, Hatano K, Ihara R, Higashihara M, Nishina Y, Tokumaru AM, Ishii K, Saito Y, Murayama S, Kanemaru K, Iwata A. CSF P-Tau181 and other biomarkers in patients with neuronal intranuclear inclusion disease. Neurology. 2023 Mar 7; 100(10):e1009-e1019.
  21. Mashiko T, Fujimoto S, Suda S, Abe A, Iguchi Y, Yagita Y, Kanzawa T, Okubo S, Todo K, Yamazaki M, Nakajima N, Kondo K, Inoue T, Iwanaga T, Terasawa Y, Shibazaki K, Kimura K, Investigators P. Prior direct oral anticoagulant dosage and outcomes in patients with acute ischemic stroke and non-valvular atrial fibrillation: A sub-analysis of PASTA registry study. J Neurol Sci. 2022;434:120163.
  22. Matsushima S, Omoto S, Shimizu T, Baba A, Ojiri H. Cauda Equina Atrophy in Amyotrophic Lateral Sclerosis on Routine Lumbar Magnetic Resonance Imaging. J Comput Assist Tomogr. 2022;46:991-6.
  23. Shigeta K, Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y, Kamiya Y, Okubo S, Hayakawa M, Ishii N, Koguchi Y, Ota T, Takigawa T, Inoue M, Naito H, Hirano T, Kato N, Ueda T, Akaji K, Iguchi Y, Miki K, Tsuruta W, Fujimoto S, Enomoto M, Aoyama J, Nakano T, Kimura K, group S study. Intravenous Alteplase is Associated with First Pass Effect in Stent-retriever but not ADAPT Thrombectomy. Clin Neuroradiol. 2022;32(1):153–62.
  24. Suda S, Nito C, Ihara M, Iguchi Y, Urabe T, Matsumaru Y, Sakai N, Kimura K, Okubo S, Takeuchi M, Takao M, Takahashi S, Morimoto M, Akaiwa Y, Ishii N, Kanzawa T, Kanai M, Yoshimura S, Hara H, Tsujino A, Kamatsuka E, Inoue T, Iwanaga T, Terasawa Y, Kanazawa R, Yasaka M, Morita K, Nakamura N, Yoshimoto T, Honma Y, Hatano T, Izumidani T, Arihiro S, Mizunari T. Randomised placebo-controlled multicentre trial to evaluate the efficacy and safety of JTR-161, allogeneic human dental pulp stem cells, in patients with Acute Ischaemic stRoke (J-REPAIR). Bmj Open. 2022;12(5):e054269.
  25. Suda S, Abe A, Iguchi Y, Yagita Y, Kanzawa T, Okubo S, Ohara N, Mizunari T, Yamazaki M, Nakajima N, Kondo K, Fujimoto S, Inoue T, Iwanaga T, Terasawa Y, Shibazaki K, Kono Y, Nakajima M, Nakajima M, Mishina M, Adachi K, Imafuku I, Nomura K, Nagao T, Yaguchi H, Okamoto S, Osaki M, Kimura K. Characteristics of Ischemic Versus Hemorrhagic Stroke in Patients Receiving Oral Anticoagulants: Results of the PASTA Study. Internal Med. 2022;61(6):801–10.
  26. Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y, Kamiya Y, Shigeta K, Okubo S, Hayakawa M, Ishii N, Koguchi Y, Takigawa T, Inoue M, Naito H, Ota T, Hirano T, Kato N, Ueda T, Iguchi Y, Akaji K, Tsuruta W, Miki K, Fujimoto S, Higashida T, Iwasaki M, Aoki J, Nishiyama Y, Otsuka T, Kimura K, Investigators for the SS. Asymptomatic Intracranial Hemorrhage Is Associated With Poor Outcomes After Mechanical Thrombectomy for Large Vessel Occlusion. Stroke Vasc Interventional Neurology. 2022;2(6).
  27. Terasawa Y, Sakai K, Arai A, Komatsu T, Mitsumura H, Iguchi Y. Timing of Valsalva maneuver and contrast injection for detecting patent foramen ovale on transesophageal echocardiography. Neurosonology. 2022;35(1):4–8.
  28. 角田亘, 大木宏一, 中島誠, 小山哲男, 大山直紀, 古賀政利, 早瀬睦, 太田剛史, 大森智裕, 松本浩一, 井口保之, 藤本茂, 小笠原邦昭. “本邦の一次脳卒中センターにおける脳卒中急性期リハビリテーションの現状”に関する多施設アンケート調査結果. 脳卒中. 2022;11058.

Ⅱ. 総説

  1. Murakami H, Shiraishi T, Umehara T, Omoto S, Iguchi Y. Recent Advances in Drug Therapy for Parkinson’s Disease. Intern Med. 2023;62:33-42.
  2. 井口保之. 脳卒中対策推進計画の予防啓発からみた脳ドックのあり方. 日本脳ドック学会報. 2022;8 (4):18-21.
  3. 井口保之. 卵円孔開存と脳梗塞. Neurosonology. 2022;35 (29):42-4.
  4. 茂木晴彦,鈴木重明.NMDA受容体脳炎,AMPA受容体脳炎の臨床と病態. 脳神経内科.2022;96:268-272.
  5. 茂木晴彦,久冨木原健二,中原仁.視神経脊髄炎スペクトラム障害(NMOSD)の新規治療薬―イネビリズマブ.脳神経内科.2022;96:446-451.
  6. 茂木晴彦,鈴木重明.免疫介在性壊死性ミオパチー.臨床免疫・アレルギー科.2022;78:423-429.
  7. 村上秀友, 白石朋敬, 梅原淳, 大本周作. Parkinson病及び類縁疾患の薬物療法の近年の進歩. 脳神経内科. 2022;96:134-139.
  8. 村上秀友. Parkinson病 近年の診断・治療方針. 東京内科医会会誌2022;38:27-30.
  9. 大本周作,村上秀友.脳神経内科 Vol. 96.東京:科学評論社;2022.P97-104.
  10. 坂井健一郎. 口腔環境と脳卒中. 脳神経内科. 2021; 97: P507-511.
  11. 作田健一,井口保之. 頸動脈の高度病変に合併する脳梗塞について:境界域脳梗塞とは何か. Current Therapy. 2022;40(7):49-53.
  12. 作田健一,井口保之. 脳梗塞.内科.2022;129(4):932-935.
  13. 作田健一,井口保之. 脳出血.内科.2022;129(4):936-935-938.
  14. 佐藤健朗. 労働・睡眠と脳卒中.脳神経内科. 2022;97:484-489.
  15. 仙石錬平.【神経難病患者の在宅医療の展望】多系統萎縮症における病診連携. 難病と在宅ケア2022;28(9):19-23.
  16. 仙石錬平.【“認知症+併存疾患”アプローチの最前線】各併存疾患の対策と管理 便秘(腸内細菌叢). 内科 2022; 129(6): 1331-1335.
  17. 須田真千子,鈴木正彦. Parkinson病とビタミンDの関連. 脳神経内科. 2022;96:734-41.
  18. 高橋 潤一郎. Parkinson病における起立性低血圧と年齢との関連. 脳神経内科. 2022;96:86-90.
  19. 谷口洋.さまざまな疾患・病態による嚥下障害の診療のポイント.脳卒中による嚥下障害.Medical Practice. 2022; 39: 997-1002.
  20. Miyamoto S, Ogasawara K, Kuroda S, Itabashi R, Toyoda K, Itoh Y, Iguchi Y, Shiokawa Y, Takagi Y, Ohtsuki T, Kinouchi H, Okada Y, Takahashi JC, Nakase H, Kakuda W, Society C for SG 2021 the Japan Stroke. Japan Stroke Society Guideline 2021 for the Treatment of Stroke. Int J Stroke. 2022;174749302210903.

Ⅲ. 症例報告

  1. Kitagawa T, Saksai K, Umehara T, Kida H, Maku T, Sato T, Takatsu H, Komatsu T, Murakami H, Mitsumura H, Iguchi Y. Repeated erythema and pain in the lateral thoracic region due to spinal cord infarction: a case report. J Neurol. 2022 Dec;269(12):6658-6660.
  2. Komatsu T, Arai A, Mitsumura H, Terasawa Y, Sakai K, Iguchi Y. Dynamic ultrasound findings in drinking and mastication steal syndrome; Case report. J Stroke Cerebrovasc Dis. 2022 Jul; 31: 106643.
  3. Komatsu T, Takahashi M, Omoto S, Iguchi Y. Asymmetric focal cortical atrophy in CSF1R-related leukoencephalopathy; case report. Acta Neurol Belg. 2022 2022;1–3.
  4. Mimori M, Komatsu T, Maku T, Mitsumura H, Iguchi Y. Generalized myasthenia gravis patients infected with COVID-19 should continue eculizumab. Neurol Sci. 2022;43(7):4081–3.
  5. Ozawa M, Sakuta K, Miyagawa S, Yaguchi H. Multiple system atrophy with anti-NAE antibody refractory to immunotherapy: A case report. Clin Neurol Neurosurg. 2022;223:107504.
  6. Yaguchi H, Sakuta K, Mukai, T, Miyagawa S. Fiberoptic laryngoscopic neurological examination of amyotrophic lateral sclerosis patients with bulbar symptoms. J Neurol Sci. 2022; 440: 120325.
  7. 浅原有揮, 須田真千子, 宮川晋治, 鈴木正彦. 重症アトピー性皮膚炎の経過中,多発脳梗塞を呈した56歳男性例. 神経治療学. 2021;38:752-756
  8. Motohashi S, Takahashi J, Umehara T, Komatsu T, Murakami H, Iguchi Y. A 73-year-old man with polyradiculopathy and multiple cranial neuropathies emerging separate from the originating dermatome of a varicella zoster skin lesion. Rinsho Shinkeigaku Clin Neurology. 2022;62(5):380–5.
  9. Sakurai T, Takahashi J, Komatsu T, et al. Anti-TIF1γ antibody-positive dermatomyositis associated with nivolumab administration in a patient with advanced esophageal squamous-cell carcinoma: a case report and literature review. Mod Rheumatol Case Rep. 2023.
  10. 岸本七生,林孝彰,須田真千子鈴木正彦,中野匡.経過中に血清interleukin-6高値を認めた動脈炎性後部虚血性視神経症の1例.臨床眼科.2022;76:1209-1217.
  11. 坂口涼子, 深澤 寧, 佐竹 真理, 牧島 玲, 小峰 多雅, 高津宏樹, 福田隆浩, 井口保之, 下田将之. 運動ニューロン徴候と軽度認知機能障害を呈したALS-TDPの一剖検例. 病理と臨床. 2022;40:613-620.

Ⅳ. 著書

  1. 井口保之. 一過性脳虚血発作の内科的治療. 高木誠, 下畑享良編著. 今日の治療指診2022年版.東京: 医学書院;2022. P938-9.
  2. 長谷川節. 破傷風.疾患別 嚥下障害. 藤島一郎監修. 東京:医歯薬出版社; 2022. P251−4.
  3. 貴田浩之, 三村秀毅, 井口保之. 脳卒中治療ガイドライン 2021. 最新臨床脳卒中学(第2版)上. 日本臨牀. 2022;645-656.
  4. 北川友通,三村秀毅,井口保之. 潜因性脳梗塞の診療:循環器内科医と脳神経内科医の協力.Heart View. 2022年7月号 Vol.26 No.7
  5. 小松鉄平, 井口保之. 第2章疾患編 1.脳梗塞 B)心原性脳塞栓症. 神経診療がわかる現場の教科書 診るロジックと薬の使い方. 東京:じほう; 2023. p 84-94.
  6. 小松鉄平, 井口保之. 【脳血管障害-脳卒中医療の今,そして未来】実地医家にとって有用な脳卒中治療に関する知識 脳梗塞の抗血小板療法の最新動向. 東京: Medical practice; 2022. p 1878-1881.
  7. 小松鉄平. 塞栓源不明脳塞栓症(ESUS)を再考する. ESUS: 軽度頸動脈病変. 東京: 脳神経内科; 2022. P 640-646
  8. 河野優. 医師国家試験から語る精神・神経疾患 ファブリー病 オーバービュー.  BRAIN and NERVE: 神経研究の進歩. 2023; 75:85-89
  9. 河野優. 若年層と脳卒中. 脳神経内科. 2022; 97:477-483
  10. 三村秀毅.井口保之.抗凝固薬.神経診療がわかる 診るロジックと薬の使い方 現場の教科書.第3章薬剤編.藤本茂(編).株式会社じほう. 2023: 390-397.
  11. 三村秀毅.非弁膜症性心房細動患者で内頸動脈狭窄がある場合,抗血栓薬はどうすべきか? 脳卒中治療Controversy.木村和美(編).2023,中外医学社.pp.294-298.
  12. 宮川晋治. 疾患別 嚥下障害東京. 中脳・橋病変:医歯薬出版株式会社. 2022: 30-33
  13. 坂井健一郎. 透析患者の非弁膜症性心房細動に対して脳梗塞の予防にワルファリンは使用すべきか. 脳卒中治療Controversy 木村和美編集. 東京:中外医学社; 2022. P299-302.
  14. 梅原 淳,井口 保之.COVID-19 神経ハンドブック(急性期,後遺症からワクチン副反応まで)Ⅲ-15. 医原性神経障害
  15. 谷口洋,作田健一.延髄外側症候群(Wallenberg症候群).疾患別嚥下障害.東京: 医歯薬出版; 2022. P40-46.
  16. 谷口洋.延髄内側症候群.疾患別嚥下障害.東京: 医歯薬出版; 2022. P48-49.
  17. 谷口洋.Guillain-Barre症候群(ギラン・バレー症候群).疾患別嚥下障害.東京: 医歯薬出版; 2022. P204-208.
  18. 谷口洋.神経系感染性疾患(VZVによる舌咽迷走神経麻痺を中心に).疾患別嚥下障害.東京: 医歯薬出版; 2022. P222-227.

Ⅴ. 研究費

  1. 三村秀毅.頸部貼付型超音波によるPFOを伴う潜因性脳梗塞の診断とPFO閉鎖術の効果判定.基盤研究(C).令和2年度〜令和5年度
  2. 村上秀友. 内因性ドパミンの賦活によるパーキンソン病の治療効果を予測する神経心理学的背景. 基盤研究(C).令和3年度〜令和7年度
  3. 白石朋敬. オートファジー障害に着目したパーキンソン病 東京慈恵会医科 モデルiPS細胞の解析.特別研究員奨励費.令和4年〜5年度
  4. 小松鉄平.間葉系幹細胞を含有したX線視認性ファイバーによる脳梗塞カテーテル治療.若手研究.令和4年度~令和6年度
  5. 松野博優.近位筋優位遺伝性運動感覚ニューロパチーの患者由来iPS細胞を用いた病態解明.研究活動スタート支援.令和3年度~令和5年度

Ⅵ. その他(代表的な学会発表など)

  1. Kida H, Sato T, Takahashi J, Nakada R, Kitagawa T, Takatsu H, Komatsu T, Sakuta K, Sakai K, Umehara T, Mitsumura H, Iguchi Y. Laterality of Carotid Plaque Is Associated with Aortic Complicated Lesion in Embolic Stroke of Undetermined Source, ISC 2023, Dallas, USA.
  2. Murakami H, Ozawa M, Shiraishi T, Umehara T, Omoto S, Iguchi Y. Association of behavioral activation system with dopaminergic striatum in Parkinson’s disease patients. American Academy of Neurology 2022 virtual meeting, Seattle, April.
  3. Okumura M, Sato T, Kokubu T, Takahashi J, Tanabe M, Onda A, Komatsu T, Sakuta K, Sakai K, Umehara T, Mitsumura H, Iguchi Y. Clinical significance of small ischemic lesions accompanied with intracerebral hemorrhage. 10th Korea-Japan Joint Stroke Conference, September 9, 2022, Osaka, Japan (Virtual)
  4. Okumura M, Sato T, Kokubu T, Takahashi J, Kitagawa T, Nakada R, Tanabe M, Onda A, Komatsu T, Sakuta K, Sakai K, Umehara T, Mitsumura H, Iguchi Y. Susceptivity Vessel Sign in Cardioembolism Due to Atrial Fibrillation: Association Between Blood Viscosity and Dihomo-γ-Linolenic Acid. International Stroke Conference, February 8, 2023, Dallas, USA.(Virtual)
  5. Sakuta K,Yaguchi H,Nakada R,Sato T,Kitagawa T,Takatsu H,MiyagawaS,Komatsu T, Sakai K,Mitsumura H,Iguchi Y. Hyperacute anterior circulation stroke due to atherosclerotic occlusion still have risks of cardioembolism. International Stroke Conference 2022. WEB, March
  6. Sato T, Matsushima S, Maku T, Kitagawa T, Tanabe M, Takatsu H, Komatsu T, Sakai K, Sakuta K, Umehara T, Murakami H, Mitsumura H, Matsushima M, Iguchi Y. Delayed leukoencephalopathy following acute ischemic stroke. International Stroke Conference, February 2023, Dallas, USA.
  7. Sato T, Okumura M, Kokubu T, Takahashi J, Tanabe M, Onda A, Komatsu T, Sakuta K, Sakai K, Umehara T, Mitsumura H, Iguchi Y. Arachidonic acid level is related to motor recovery in intracerebral hemorrhage with severe motor paralysis. 10th Korea-Japan Joint Stroke Conference, September 2022, Osaka, Japan.
  8. Takahashi J, Komatsu T, Okumura M, Kida H, Maku T, Nakata R, Kitagawa T, Sato T, Takatsu H, Sakuta K, Sakai K, Mitsumura H, Iguchi Y. Impact of Silent Liver Fibrosis on the Presence, Distribution, and Burden of Cerebral Microbleeds in Patients with Acute Ischemic Stroke. International Stroke Conference 2023. Dallas+Virtual, February 8-10.
  9. Ishikawa T, Sato T, Okumura M, Kokubu T, Takahashi J, Kitagawa T, Tanabe M, Onda A, Komatsu T, Sakuta K, Sakai K, Umehara T, Mitsumura H, Iguchi Y. Ischemic Stroke While Bathing: Stroke Subtype and Association With Cerebral Small Vessel Disease. International Stroke Conference, February 2023, Dallas, USA.
  10. Sato T, Matsushima S, Maku T, Kitagawa T, Tanabe M, Takatsu H, Komatsu T, Sakai K, Sakuta K, Umehara T, Murakami H, Mitsumura H, Iguchi Y. Delayed leukoencephalopathy following acute ischemic stroke. 63rd Annual Meeting of the Japanese Society of Neurology, May 2022, Tokyo, Japan.
最上部へ
東京慈恵会医科大学 内科学講座 脳神経内科

〒105-8461 東京都港区西新橋3-25-8